The PORT for Health: Oncology 2022 conference held at Łukasiewicz – PORT has come to an end. It was a unique opportunity to learn about the latest research results and emerging directions in studies on the causes and treatment of cancer.
Over three days (28–30 September 2022), our Institute hosted outstanding scientists, clinicians, and representatives of the pharmaceutical industry from Europe and the United States. Participants attended more than 20 lectures devoted to research on the biological basis of cancer, precision therapies, and diagnostics in oncology. The conference also included a partner session of the Virtual Research Institute (WIB).
Lectures were delivered by:
Piotr Donizy (Wroclaw Medical University)
Agi Grigoriadis (King’s College London, United Kingdom)
Lucy Yates (Wellcome Trust Sanger Institute, United Kingdom)
Sussane Schlisio (Karolinska Institute, Sweden)
Bożena Kamińska-Kaczmarek (Nencki Institute of Experimental Biology, Polish Academy of Sciences)
Małgorzata Krajewska (University College Cork, Ireland)
Rachael Natrajan (Institute of Cancer Research, United Kingdom)
Özdemirhan Serçin (BioMed X, Germany)
Gabriela Kramer-Marek (Institute of Cancer Research, United Kingdom)
Sheeba Irshad (King’s College London, United Kingdom)
Adrian Hayday (King’s College London, United Kingdom)
Richard Beatson (University College London, United Kingdom)
Grzegorz Chodaczek (Łukasiewicz – PORT)
Tomasz Zal (Immatics, USA)
Anita Grigoriadis (King’s College London, United Kingdom)
Roberto Salgado (University Hospital of Antwerp, Belgium)
Piotr Ziółkowski (Wroclaw Medical University)
Krzysztof Żółtański (Vialutions)
Andreas Pohling (Vialutions)
Speakers in the WIB partner session included:
Andrzej Dziembowski (International Institute of Molecular and Cell Biology in Warsaw, leader of the HERO team selected in the first WIB call)
Jacek Jemielity (University of Warsaw, member of the HERO team)
Piotr Kowalski (University College Cork, Ireland)
Stephen Schoenberger (La Jolla Institute for Immunology, USA)
The PORT for Health: Oncology 2022 conference was held in a hybrid format, with more than 20 hours of live streaming for online participants.
An accompanying event was the satellite session “Towards Excellence in Biobanking”, held on 28 September 2022.
We would like to thank the partners and sponsors who supported the organization of the event:
Virtual Research Institute (WIB)
PERLAN Technologies Polska Sp. z o.o.
Spektrometria
Olympus Evident
Central European BioForum
The media partner of the conference was Biotechnologia.pl.
More information about the conference.
The project was selected for funding by the Ministry of Education and Science under the programme “Excellent Science”, module “Support for Scientific Conferences.”
Funding application number: DNK/SP/547342/2022.
